publication date: Mar. 11, 2016

Slamming the Door

Part VII – DePinho’s Stock Tip Revisited


By Paul Goldberg

On May 25, 2012, I received an email from Len Zwelling:

Paul: It can’t get worse than having our President pushing his own stock on TV. Len

I clicked on the provided link to CNBC. What I saw was indeed difficult to process: a video of Ron DePinho, extolling the virtues of the stock of AVEO Pharmaceuticals Inc., a company he co-founded.

On the CNBC program “Closing Bell with Maria Bartiromo” May 18, DePinho brought up AVEO in the context of the upcoming meeting of the American Society of Clinical Oncology.

Here is a transcript of the appearance:

MARIA BARTIROMO: Are there companies out there, from an investment standpoint; for our audiences are obviously looking for money-making opportunities, trying to figure out how to capitalize on what’s going on in this marriage of health care and technology and biotech. Are there companies out there that you think are most promising, and also what is going to come out of this ASCO meeting, you think?

RONALD DePINHO: Well, the companies in the biotech sector, you have to be very careful because you have to really understand which companies are driven by good management, that are driven by the kinds of scientific advances that I’ve mentioned, and there are a few of them out there. … Continue reading 42-10 Slamming the Door Part VII – DePinho’s Stock Tip Revisited

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.